Results 171 to 180 of about 1,155,481 (241)

Pyrimidine-based NNRTIs in HIV therapy: advances in synthesis, potency and structure-activity relationships. [PDF]

RSC Adv
Ali H, Hashmi MA, Ajmal N, Goraija MS, Rasool N, Siddiqua UH, Malik A.   +6 more
europepmc   +1 more source

M184I/V substitutions and E138K/M184I/V double substitutions in HIV reverse transcriptase do not significantly affect the antiviral activity of EFdA. [PDF]

J Antimicrob Chemother, 2017
Oliveira M, Brenner BG, Xu H, Ibanescu RI, Mesplède T, Wainberg MA.   +5 more
europepmc   +1 more source

A French National Real-World Survey of People With Multiresistant HIV-1 Viruses Receiving an Antiretroviral Regimen Including Fostemsavir or Ibalizumab. [PDF]

Open Forum Infect Dis
Stefic K, Tumiotto C, de Monte A, Wirden M, Rodallec A, Fofana D, Chaix ML, Bellecave P, Garnier E, Sourice J, Vellas C, Raymond S, Lambert-Niclot S, Alidjinou EK, Coulon P, Avettand-Fenoel V, Mchantaf G, Handala L, Alessandri-Gradt E, Moisan A, Lê M, Delaugerre C, Marcelin AG, Peytavin G, Calvez V, Descamps D, Charpentier C, Entry Inhibitors Observatory Study Group, Entry Inhibitors Observatory Study Group .   +28 more
europepmc   +1 more source

Association between infant post-natal prophylaxis regimens and pretreatment HIV drug resistance in infected infants. [PDF]

Front Epidemiol
Inzaule SC, Kingwara L, Akanmu AS, Hamers RL, Jordan MR, Girón-Callejas A, Madada RS, Nyagah L, Onwonga V, Penazzato M, Bertagnolio S, Rangaraj A, Kimenye K, Rinke de Wit TF, Mula A.   +14 more
europepmc   +1 more source

HIV-1 Resistance to Dolutegravir in Benin: The Need to Improve and Strengthen Therapeutic Patient Education Strategies to Achieve the Third Objective 95 of UNAIDS 95-95-95 Target. [PDF]

Case Rep Infect Dis
Tchiakpe E, Diop-Ndiaye H, Osawe S, Toure-Kane C, Yessoufou A.   +4 more
europepmc   +1 more source

Baseline HIV Genotyping and Antiretroviral Therapy Resistance Mutations in Saudi Arabian Population, a Multicentre, Cross-Sectional Study. [PDF]

Viruses
Al-Osaimi R, Al-Qurashi M, Al-Zamil L, Ali B, Al-Mutairy R, Al-Saeed A, Al-Shelawi M, Al-Khalaf A, Al-Subaie A, Faqih L.   +9 more
europepmc   +1 more source

HIV-1 genetic diversity and reverse transcriptase resistance mutations in Benin before dolutegravir era, West Africa. [PDF]

PLoS One
Tchiakpe E, Keke RK, Recordon-Pinson P, Diouara AAM, Andreola ML, Bachabi M, Afangnihoun A, Gbaguidi E, Osawe S, Issiaka Maiga A, Diop-Ndiaye H, Touré-Kane C, Yessoufou A.   +12 more
europepmc   +1 more source

Research progress on HIV-1 structural proteins and antiviral therapies. [PDF]

Front Immunol
Wang H, Yuan J, Wang H.
europepmc   +1 more source

Ultrasound for the determination of appropriate needle length for intragluteal injection of long-acting rilpivirine-cabotegravir. [PDF]

HIV Med
Gueuning C, Brizmohun M, Dauby N, Martin C.   +3 more
europepmc   +1 more source

Hiding in Plain Sight: HIV-1 Membraneless Organelles as Nuclear Hubs-Host Hijacking, Replication, Immune Evasion, and Drug-Access Implications. [PDF]

Pathogens
Broccolo F, Sannino A, Pollini M, Paladini F, Mourer T, Di Nunzio F.   +5 more
europepmc   +1 more source